Dectin-1 (CLEC7A), a C-type lectin receptor, exhibits dual roles in cancer immunity, acting as either an immunosuppressive or immunostimulatory agent depending on the tumor context and ligand availability. The gene discussed is CLEC4D; the disease is neoplasm.